Heterologous prime/boost immunizations of rhesus monkeys using chimpanzee adenovirus vectors
Sampa Santra(Beth Israel Deaconess Medical Center), Norman L. Letvin(Beth Israel Deaconess Medical Center), Cherie Charbonneau(Beth Israel Deaconess Medical Center), Birgit Korioth-Schmitz(Beth Israel Deaconess Medical Center), Hildegund C.J. Ertl(The Wistar Institute), Gary J. Nabel(National Institutes of Health), Michael S. Seaman(Beth Israel Deaconess Medical Center), Yue Sun(Nanyang Technological University), Julie C. Fitzgerald(Children's Hospital of Philadelphia), Sarah J. Ratcliffe(University of Virginia Health System), Giannina Santos(Harvard University), David C. Montefiori(Duke University)
Cited by 49
Related Papers
Tracking Changes in SARS-CoV-2 Spike: Evidence that D614G Increases Infectivity of the COVID-19 Virus
|Cell|2020|4.5k
Persistence and Evolution of SARS-CoV-2 in an Immunocompromised Host
|New England Journal of Medicine|2020|1.4k
Immune correlates analysis of the mRNA-1273 COVID-19 vaccine efficacy clinical trial
|Science|2022|1.2k